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The Editorial on the Research Topic
Microorganisms for Functional Food
Notwithstanding the European Food Safety Authority (EFSA) did not approve any health
claims for probiotic foods [including terms such as “probiotic,” “active bacteria”; European
Commission (EC), 2007], most of the research studies in the field of microorganisms used for
obtaining functional food deal with (putatively) probiotic bacteria. Probiotics may positively
affect human/animal health in several ways, such as by inhibiting gut pathogenic microorganisms
(Delgado et al.), modulating immune response, lowering concentration of cholesterol in
blood (Damodharan et al.), and exerting antioxidant activity. The mechanisms underlying
the health effects of probiotic bacteria raise great interest among researchers. Modulation
of the host gut microbiome represents an intriguing mechanism and is the subject of two
research articles (Yang et al.; Senan et al.) published in this Research Topic. In detail,
reutericyclin, a broad spectrum antimicrobial compound produced by Lactobacillus reuteri
during feed fermentation, increased the abundance of Dialister and Mitsuokella, two Firmicutes
genera that are gut commensals in weanling pigs (Yang et al.). Senan et al. reported that
differences in gut microbiome composition (especially for Lactobacillus, Clostridium, Eubacterium,
Blautia, Shigella, Escherichia, Burkholderia, and Campylobacter) affected the response of geriatric
individuals to Lassi, a fermented milk containing a cholesterol-lowering strain of Lactobacillus
helveticus.
Evaluation assays of probiotic potential are traditionally classified in two groups: “in vitro”
and “in vivo.” The use of omics approaches is going to flank the traditional assays,
thus probably speeding up research progress in the field of probiotics in the near future.
For instance, sequencing of genomes will allow to rapidly detect and discard candidate
probiotic microorganisms possessing genes coding for antibiotic resistance or virulence
factors (Papadimitriou et al.). In this regard, an excellent example is provided in this
Research Topic by Balzaretti et al. which performed comparative genome analysis of four
strains of Lactobacillus paracasei in order to select the two best probiotic strains for oral
usage. Anyway, in vivo approaches will keep on being unreplaceable, given the variability
of host response to probiotics as affected by genotype, age, diet, variations in human
environmental exposure, and composition of gut microbiome (Turnbaugh et al., 2009; Senan
et al.).
Besides the understanding of the mechanisms underlying probiotic activities and studies
dealing with interactions between probiotic microorganisms and gut microbiome, other
future perspectives about microorganisms for functional food are: (i) novel putative probiotic
bacteria, such as Akkermansia muciniphila and Faecalibacterium prausnitzii (Varankovich et al.);
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(ii) non-dairy food items (e.g., table olives) as carriers of probiotic
bacteria (Rodríguez-Gómez et al.; Arroyo-López et al.); (iii)
health effects of microbial metabolites (Yu et al.; Garrote et al.);
and (iv) probiotic interventions on livestock indirectly benefiting
human health (Yang et al.).
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